The Viral Vector & Plasmid DNA Manufacturing Market Size accounted for USD 5.4 Billion in 2023 and is estimated to achieve a ...

The popularity of viral vector-based gene therapies and vaccines is rapidly growing. However, it is often difficult for scientists to ramp up the generation of these vectors to meet their needs at ...

To meet patient needs, reliable and cost-effective manufacturing processes are crucial. Yet, the complexity of scaling viral vector processes to commercial levels and the absence of standardized ...

Signal Hound–manufacturer of accessible, versatile, precision test equipment–announced the release of the VNA400 to its ...